AH
Anita Harichand Thakur
About Anita Harichand Thakur
Data last updated:
Anita Harichand Thakur is a Director at Indo Asian Buildcon Private Limited (since 2019) and Designated Partner at Indo Asian Pharmaceuticals Llp (since 2020). The companies operate in Real Estate and Construction and Electrnoics. The largest current company by reported revenue is Indo Asian Buildcon Private Limited at ₹2.30 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Indo Asian Buildcon Private Limited U70102MH2011PTC222788 | Director | 13 Dec 2019 | 2011 | ₹2.30 Cr (FY 2025) | Active |
| Indo Asian Pharmaceuticals Llp AAS-8680 | Designated Partner | 13 Jul 2020 | 2020 | Active |
Board colleagues of Anita Harichand Thakur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhan Bahadur Gagan Chand | 03573487 | Indo Asian Buildcon Private Limited , Indo Asian Pharmaceuticals Llp | Director |
| Gurpreet Kaur Sehgal | 10442115 | Indo Asian Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anita Harichand Thakur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anita Harichand Thakur
Anita Harichand Thakur currently holds 2 directorships: Indo Asian Buildcon Private Limited (Director, since 13 Dec 2019, revenue ₹2.30 Cr (FY 2025)); Indo Asian Pharmaceuticals Llp (Designated Partner, since 13 Jul 2020).
Anita Harichand Thakur was first appointed on 13 Dec 2019 as Director at Indo Asian Buildcon Private Limited. The most recent appointment on record is 13 Jul 2020 at Indo Asian Pharmaceuticals Llp.
The current boards of Anita Harichand Thakur's companies include Dhan Bahadur Gagan Chand (Indo Asian Buildcon Private Limited), Gurpreet Kaur Sehgal (Indo Asian Pharmaceuticals Llp).